Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MMSI · against 234 other Healthcare companies of similar size
Ranked #97 of 235 · scores higher than 58% of peers
Bars: peers in each 10-point band of the valuation score35 peers with a valuation score of 60–69, including MMSI · Click a bar to see the companies
Mainly thanks to its free cash flow yield, EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | MMSI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 233 reported | 2.9% | 2.5% | 57% | 30% | |
| EBITDA yieldHigher is better · 232 reported | 6.3% | 4.5% | 65% | 50% | |
| Free cash flow yieldHigher is better · 126 reported | 4.0% | 0.8% | 76% | 20% | |
| Book yieldHigher is better · 234 reported | 33.4% | 26.0% | 60% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 4 | 21.1B HKD (≈$2.7B) | 98 | 67 | |
| 4 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 95 | 626.0B INR (≈$7.5B) | 61 | 68 | |
| 95 | 4.4B CHF (≈$5.1B) | 61 | 47 | |
| 97 | 32.3B CNY (≈$4.5B) | 60 | 55 | |
| 97 | 23.2B CNY (≈$3.2B) | 60 | 62 | |
| 97 | 5.0B USD | 60 | 60 | |
| 100 | 4.3B USD | 59 | 54 | |
| 100 | 3.8B USD | 59 | 71 | |
| 100 | 5.3B USD | 59 | 63 | |
| 103 | 19.0B CNY (≈$2.7B) | 58 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score